Showing results (1111-1120 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|January 16, 1999
Economic evaluation of cancer treatments: methodological and practical issuesC A Uyl-de Groot, C R TouwAnti-Cancer Drugs|May 4, 2001
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxelM M Malingré, J H Beijnen, H Rosing, et al.Anti-Cancer Drugs|May 4, 2001
Antitumor activity of XR5944, a novel and potent topoisomerase poisonA J Stewart, P Mistry, W Dangerfield, et al.Anti-Cancer Drugs|August 21, 2002
Gemtuzumab Ozogamicin (CMA-676, Mylotarg) for the treatment of CD33+ acute myeloid leukemiaIoannis A VoutsadakisAnti-Cancer Drugs|August 21, 2002
In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemiaB-M Frost, G Lönnerholm, P Nygren, et al.Anti-Cancer Drugs|August 13, 2002
Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancerWinnie Yeo, Tony S K Mok, Kin K Tse, et al.Anti-Cancer Drugs|August 13, 2002
Continuation of regional chemotherapy of hepatic neoplasms despite occlusion of the hepatic artery-report of four casesBert Hildebrandt, Lars Meyer, Wolf-Otto Bechstein, et al.Anti-Cancer Drugs|August 14, 2002
Safety and efficacy of ET-743: the French experienceEtienne G C BrainAnti-Cancer Drugs|August 14, 2002
ET-743: more than an innovative mechanism of actionKathleen W ScottoAnti-Cancer Drugs|October 24, 2002
Neo-adjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancerPaolo Alberto Paciucci, George Raptis, Ira Bleiweiss, et al.Pageof 464